{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:21:42Z","timestamp":1762899702081},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To determine whether cataract or glaucoma and combined cataract and glaucoma surgery (CGS) affect glaucoma medication usage.<\/jats:p>\n            <jats:p>We recruited patients who received new diagnoses of glaucoma, either primary open-angle glaucoma (POAG) (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 365.1) or primary angle-closure glaucoma (PACG) (ICD-9-CM code 365.2), between 1998 and 2011 and had undergone cataract surgery alone (CS), glaucoma surgery alone (GS), or CGS under the National Health Insurance program in Taiwan. CS, GS, and CGS in all the patients were performed after the glaucoma diagnosis date. The patients were subdivided into CS, CGS, and GS groups. The number of glaucoma medications, including prostaglandin analogs, \u03b2-blockers, carbonic anhydrase inhibitors, \u03b1-agonists, pilocarpine, and a combination of drugs, in each prescription, were compared before and after surgery.<\/jats:p>\n            <jats:p>The mean number of glaucoma medications in each prescription before the surgery increased from approximately 0.5\/1\u200a(CS\/CGS + GS) to a peak of 1.75\/3 within 3 months before the index date. The mean number of glaucoma medications in each prescription reduced to 0 (CS group) and to approximately 0.5 (CGS and GS) at the end of the 3-year follow-up period. The mean number of glaucoma medications in each prescription significantly reduced at the time points within 6 months, between 6 months and 2 years, and during 2 to 3 years after surgery in each group. At the end of the 3-year period, the reduction effect was most evident in the CS group. Similar trends were also observed in the POAG and PACG group.<\/jats:p>\n            <jats:p>CS, GS, and CGS significantly reduced the number of glaucoma medications used by the glaucoma patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014128","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:15:32Z","timestamp":1548400532000},"page":"e14128","source":"Crossref","is-referenced-by-count":7,"title":["Changes in glaucoma medication numbers after cataract and glaucoma surgery"],"prefix":"10.1097","volume":"98","author":[{"given":"Hsin-Yi","family":"Chen","sequence":"first","affiliation":[{"name":"College of Medicine"},{"name":"Department of Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[{"name":"College of Medicine"},{"name":"Management Office for Health Data"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hung","family":"Kao","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Sciences and School of Medicine, College of Medicine"},{"name":"Department of Nuclear Medicine and PET Center, China Medical University Hospital"},{"name":"Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.survophthal.2017.08.006","article-title":"The role of phacoemulsification in glaucoma therapy: a systematic review and meta-analysis","volume":"63","author":"Masis","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jcrs.2017.03.044","article-title":"Anterior segment parameters as predictors of intraocular pressure reduction after phacoemulsification in eyes with open-angle glaucoma","volume":"43","author":"Hsia","year":"2017","journal-title":"J Cataract Refract Surg"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/IJG.0000000000000643","article-title":"The effects of phacoemulsification on intraocular pressure and topical medication use in patients with glaucoma: a systematic review and meta-analysis of 3-year data","volume":"26","author":"Armstrong","year":"2017","journal-title":"J Glaucoma"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2015.03.021","article-title":"The effect of phacoemulsification on intraocular pressure in glaucoma patients: a report by the American academy of ophthalmology","volume":"122","author":"Chen","year":"2015","journal-title":"Ophthalmology"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(16)30956-4","article-title":"EAGLE study group. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial","volume":"388","author":"Azuara-Blanco","year":"2016","journal-title":"Lancet"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/APO.0000000000000174","article-title":"Lowering of intraocular pressure after phacoemulsification in primary open-angle and angle-closure glaucoma: a bayesian analysis","volume":"5","author":"Thomas","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1442-9071.2011.02617.x","article-title":"There is insufficient evidence to recommend lens extraction as a treatment for primary open-angle glaucoma: an evidence-based perspective","volume":"40","author":"Walland","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/ICU.0b013e3283360ac3","article-title":"The effect of cataract extraction on intraocular pressure","volume":"21","author":"Shrivastava","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/ICU.0b013e328332f562","article-title":"Cataract surgery and glaucoma","volume":"21","author":"Vizzeri","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jcrs.2014.06.001","article-title":"Lens-based glaucoma surgery: using cataract surgery to reduce intraocular pressure","volume":"40","author":"Brown","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcrs.2014.10.019","article-title":"Lens surgery to treat open-angle glaucoma: triumph of hope over (evidence-based) experience","volume":"41","author":"Walland","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R12-20230914","first-page":"CD008671","article-title":"Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma","volume":"14","author":"Zhang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1745-6215-12-133","article-title":"The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial","volume":"12","author":"Azuara-Blanco","year":"2011","journal-title":"Trials"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"e013254","DOI":"10.1136\/bmjopen-2016-013254","article-title":"Early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: an economic evaluation based on data from the EAGLE trial","volume":"7","author":"Javanbakht","year":"2017","journal-title":"BMJ Open"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/IJG.0000000000000969","article-title":"Changes in ocular hypotensive drug usage for glaucoma treatment after cataract surgery: a nationwide population-based study in Taiwan","volume":"27","author":"Chang","year":"2018","journal-title":"J Glaucoma"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1851568","DOI":"10.1155\/2017\/1851568","article-title":"Association of neovascular glaucoma with risk of stroke: a population-based cohort study","volume":"2017","author":"Su","year":"2017","journal-title":"J Ophthalmol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"e3670","DOI":"10.1097\/MD.0000000000003670","article-title":"Does migraine increase the risk of glaucoma?: a population-based cohort study","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:29:12Z","timestamp":1694716152000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00024"}},"subtitle":["A nationwide population-based study"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014128","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}